SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 119, Issue 11, Pages 1358-1366
Publisher
Springer Nature
Online
2018-11-07
DOI
10.1038/s41416-018-0338-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell
- (2018) Chenzhe Feng et al. CELL CYCLE
- Emerging molecular therapeutic targets for cholangiocarcinoma
- (2017) Sumera Rizvi et al. JOURNAL OF HEPATOLOGY
- Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer
- (2016) Zhongxing Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
- (2016) Laura Garros-Regulez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma
- (2016) Chungang Liu et al. HEPATOLOGY
- Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
- (2015) A. Moeini et al. CLINICAL CANCER RESEARCH
- Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma
- (2015) Hajime Matsushima et al. DIGESTIVE AND LIVER DISEASE
- Lineage fate of ductular reactions in liver injury and carcinogenesis
- (2015) Simone Jörs et al. JOURNAL OF CLINICAL INVESTIGATION
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Changing pattern of epidemiology in intrahepatic cholangiocarcinoma
- (2013) Basile Njei HEPATOLOGY
- Sox9 and programming of liver and pancreatic progenitors
- (2013) Yoshiya Kawaguchi JOURNAL OF CLINICAL INVESTIGATION
- Caveolin-1 abrogates TGF-β mediated hepatocyte apoptosis
- (2013) C Meyer et al. Cell Death & Disease
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
- (2011) Erika Pastrana et al. Cell Stem Cell
- Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets
- (2011) Vincenzo Cardinale et al. HEPATOLOGY
- Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages
- (2011) Guido Carpino et al. JOURNAL OF ANATOMY
- Understanding the role of SOX9 in acquired diseases: lessons from development
- (2011) James Pritchett et al. TRENDS IN MOLECULAR MEDICINE
- Organogenesis and Development of the Liver
- (2010) Karim Si-Tayeb et al. DEVELOPMENTAL CELL
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrahepatic Bile Ducts Develop According to a New Mode of Tubulogenesis Regulated by the Transcription Factor SOX9
- (2009) Aline Antoniou et al. GASTROENTEROLOGY
- The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin-13 as driving forces in fibrogenesis
- (2009) Hong-Lei Weng et al. HEPATOLOGY
- Long-range regulation at the SOX9 locus in development and disease
- (2009) C T Gordon et al. JOURNAL OF MEDICAL GENETICS
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started